Skip to main content
. Author manuscript; available in PMC: 2017 Jul 19.
Published in final edited form as: Anal Chem. 2016 Jun 24;88(14):7091–7100. doi: 10.1021/acs.analchem.6b00963

Figure 7.

Figure 7

The percentage of N-glycan site occupancy for six rMAb drugs, where occupied sites possessed aspartic acid (D) residues and unoccupied sites possessed asparagine (N) residues after PNGase F treatment.